153 related articles for article (PubMed ID: 25807844)
1. Subclinical systemic and vascular inflammation detected by (18) F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with mild psoriasis.
Youn SW; Kang SY; Kim SA; Park GY; Lee WW
J Dermatol; 2015 Jun; 42(6):559-66. PubMed ID: 25807844
[TBL] [Abstract][Full Text] [Related]
2. Systemic and vascular inflammation in patients with moderate to severe psoriasis as measured by [18F]-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT): a pilot study.
Mehta NN; Yu Y; Saboury B; Foroughi N; Krishnamoorthy P; Raper A; Baer A; Antigua J; Van Voorhees AS; Torigian DA; Alavi A; Gelfand JM
Arch Dermatol; 2011 Sep; 147(9):1031-9. PubMed ID: 21576552
[TBL] [Abstract][Full Text] [Related]
3. Thresholds for Arterial Wall Inflammation Quantified by
van der Valk FM; Verweij SL; Zwinderman KA; Strang AC; Kaiser Y; Marquering HA; Nederveen AJ; Stroes ES; Verberne HJ; Rudd JH
JACC Cardiovasc Imaging; 2016 Oct; 9(10):1198-1207. PubMed ID: 27639759
[TBL] [Abstract][Full Text] [Related]
4. Measurement of arterial activity on routine FDG PET/CT images improves prediction of risk of future CV events.
Figueroa AL; Abdelbaky A; Truong QA; Corsini E; MacNabb MH; Lavender ZR; Lawler MA; Grinspoon SK; Brady TJ; Nasir K; Hoffmann U; Tawakol A
JACC Cardiovasc Imaging; 2013 Dec; 6(12):1250-9. PubMed ID: 24269261
[TBL] [Abstract][Full Text] [Related]
5. Increased global arterial and subcutaneous adipose tissue inflammation in patients with moderate-to-severe psoriasis.
Hjuler KF; Gormsen LC; Vendelbo MH; Egeberg A; Nielsen J; Iversen L
Br J Dermatol; 2017 Mar; 176(3):732-740. PubMed ID: 27787888
[TBL] [Abstract][Full Text] [Related]
6. A positron emission tomography/computed tomography (PET/CT) evaluation of asymptomatic abdominal aortic aneurysms: another point of view.
Palombo D; Morbelli S; Spinella G; Pane B; Marini C; Rousas N; Massollo M; Cittadini G; Camellino D; Sambuceti G
Ann Vasc Surg; 2012 May; 26(4):491-9. PubMed ID: 22197524
[TBL] [Abstract][Full Text] [Related]
7. A pilot trial to examine the effect of high-dose niacin on arterial wall inflammation using fluorodeoxyglucose positron emission tomography.
deGoma EM; Salavati A; Shinohara RT; Saboury B; Pollan L; Schoen M; Torigian DA; Mohler ER; Dunbar RL; Litt HI; Woo J; Rader DJ; Alavi A; Mehta NN
Acad Radiol; 2015 May; 22(5):600-9. PubMed ID: 25708866
[TBL] [Abstract][Full Text] [Related]
8. Relationships among regional arterial inflammation, calcification, risk factors, and biomarkers: a prospective fluorodeoxyglucose positron-emission tomography/computed tomography imaging study.
Rudd JH; Myers KS; Bansilal S; Machac J; Woodward M; Fuster V; Farkouh ME; Fayad ZA
Circ Cardiovasc Imaging; 2009 Mar; 2(2):107-15. PubMed ID: 19808576
[TBL] [Abstract][Full Text] [Related]
9. FDG PET/CT for evaluating systemic arterial inflammation induced by anthracycline-based chemotherapy of Hodgkin lymphoma: A retrospective cohort study.
Lawal IO; Orunmuyi AT; Popoola GO; Lengana T; Mokoala KMG; Ankrah AO; Sathekge MM
Medicine (Baltimore); 2020 Nov; 99(48):e23259. PubMed ID: 33235083
[TBL] [Abstract][Full Text] [Related]
10. Relationship between fluorodeoxyglucose uptake in the large vessels and late aortic diameter in giant cell arteritis.
Blockmans D; Coudyzer W; Vanderschueren S; Stroobants S; Loeckx D; Heye S; De Ceuninck L; Marchal G; Bobbaers H
Rheumatology (Oxford); 2008 Aug; 47(8):1179-84. PubMed ID: 18515868
[TBL] [Abstract][Full Text] [Related]
11. Comparison of atorvastatin 5 and 20 mg/d for reducing F-18 fluorodeoxyglucose uptake in atherosclerotic plaques on positron emission tomography/computed tomography: a randomized, investigator-blinded, open-label, 6-month study in Japanese adults scheduled for percutaneous coronary intervention.
Ishii H; Nishio M; Takahashi H; Aoyama T; Tanaka M; Toriyama T; Tamaki T; Yoshikawa D; Hayashi M; Amano T; Matsubara T; Murohara T
Clin Ther; 2010 Dec; 32(14):2337-47. PubMed ID: 21353104
[TBL] [Abstract][Full Text] [Related]
12. 18F-FDG PET/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic disease.
Rominger A; Saam T; Wolpers S; Cyran CC; Schmidt M; Foerster S; Nikolaou K; Reiser MF; Bartenstein P; Hacker M
J Nucl Med; 2009 Oct; 50(10):1611-20. PubMed ID: 19759117
[TBL] [Abstract][Full Text] [Related]
13. Effects of age and cardiovascular risk factors on (18)F-FDG PET/CT quantification of atherosclerosis in the aorta and peripheral arteries.
Pasha AK; Moghbel M; Saboury B; Gharavi MH; Blomberg BA; Torigian DA; Kwee TC; Basu S; Mohler Iii ER; Alavi A
Hell J Nucl Med; 2015; 18(1):5-10. PubMed ID: 25679072
[TBL] [Abstract][Full Text] [Related]
14. Imaging of atherosclerotic aorta of rabbit model by detection of plaque inflammation with fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography.
Zhao QM; Feng TT; Zhao X; Xu ZM; Liu Y; Li DP; Li LQ; Su G; Zhang XX
Chin Med J (Engl); 2011 Mar; 124(6):911-7. PubMed ID: 21518602
[TBL] [Abstract][Full Text] [Related]
15. Effects of the tumor necrosis factor-α antagonist adalimumab on arterial inflammation assessed by positron emission tomography in patients with psoriasis: results of a randomized controlled trial.
Bissonnette R; Tardif JC; Harel F; Pressacco J; Bolduc C; Guertin MC
Circ Cardiovasc Imaging; 2013 Jan; 6(1):83-90. PubMed ID: 23204039
[TBL] [Abstract][Full Text] [Related]
16. A Study of the Feasibility of FDG-PET/CT to Systematically Detect and Quantify Differential Metabolic Effects of Chronic Tobacco Use in Organs of the Whole Body-A Prospective Pilot Study.
Torigian DA; Green-McKenzie J; Liu X; Shofer FS; Werner T; Smith CE; Strasser AA; Moghbel MC; Parekh AH; Choi G; Goncalves MD; Spaccarelli N; Gholami S; Kumar PS; Tong Y; Udupa JK; Mesaros C; Alavi A
Acad Radiol; 2017 Aug; 24(8):930-940. PubMed ID: 27769824
[TBL] [Abstract][Full Text] [Related]
17. Inflammation in the walls of asymptomatic abdominal aortic aneurysms is not associated with increased metabolic activity detectable by 18-fluorodeoxglucose positron-emission tomography.
Tegler G; Ericson K; Sörensen J; Björck M; Wanhainen A
J Vasc Surg; 2012 Sep; 56(3):802-7. PubMed ID: 22854268
[TBL] [Abstract][Full Text] [Related]
18. The role of (18) F-fluorodeoxyglucose-positron emission tomography in the assessment of disease activity in patients with takayasu arteritis.
Lee KH; Cho A; Choi YJ; Lee SW; Ha YJ; Jung SJ; Park MC; Lee JD; Lee SK; Park YB
Arthritis Rheum; 2012 Mar; 64(3):866-75. PubMed ID: 21989701
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal Assessment of Inflammatory Activity in Acute Type B Aortic Dissection with Integrated Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging.
Kuzniar M; Wanhainen A; Tegler G; Hansen T; Mani K
Eur J Vasc Endovasc Surg; 2023 Sep; 66(3):323-331. PubMed ID: 37247689
[TBL] [Abstract][Full Text] [Related]
20. HIV infection and arterial inflammation assessed by (18)F-fluorodeoxyglucose (FDG) positron emission tomography (PET): a prospective cross-sectional study.
Knudsen A; Hag AM; Loft A; von Benzon E; Keller SH; Møller HJ; Lebech AM; Ripa RS; Kjær A
J Nucl Cardiol; 2015 Apr; 22(2):372-80. PubMed ID: 25467249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
